Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii in AAD Prevention
NCT05261152Phase 4Completed
- Sponsor
- University Clinical Center of Serbia
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in antibiotic-associated diarrhea (AAD) comparing Probiotic group with Placebo group (2 arms). Primary endpoints: Gastrointestinal symptoms and signs at 21 days and Fever at 21 days. Started Nov 2017; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT05261152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05261152.